Faeezah Patel

5PUBLICATIONS
61CO-AUTHORS
Haematological tumoursInfant and child healthInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 11, 2025
Clot twist - D-dimer analysis of healthy adults receiving heterologous or homologous booster COVID-19 vaccine after a single prime dose of Ad26.COV2.S in a phase II randomised open-label trial, BaSiS.

F Patel, J Le Roux, S Sawry

|May 29, 2025
Efficacy, Safety and Tolerability of Dispersible and Immediate Release Abacavir/Dolutegravir/Lamivudine Tablets in Children With HIV: IMPAACT 2019 Week 48 Results.

Helena Rabie, Dwight E Yin, Shawn Ward

|Dec 05, 2024
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.

Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma

|Apr 11, 2024
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.

Catherine Riou, Jinal N Bhiman, Yashica Ganga

|Dec 04, 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.

Catherine Riou, Jinal N Bhiman, Yashica Ganga

Pageof 1

Frequent Collaborators

3 joint publications

Jean Le Roux

3 joint publications

Shobna Sawry

3 joint publications

Mrinmayee Dhar

3 joint publications

Helen Rees